Home

 
 
 

Elevating the Treatment of Cancer

The Summit Is Clear

once you pass through the clouds

We believe that every patient deserves to know what is driving the growth of their cancer and how best to treat it

 
 
 

Elevating precision medicine to the forefront of every cancer treatment journey

Our vision is a future in which each tumor’s unique genomic test result can be matched with a purpose-built precision medicine.

Together with our drug and diagnostic developer peers, we work to enable a personalized treatment plan for each individual patient with cancer.

Our Focus
 
 
 

Genomic testing illuminates the path

Your tumor has a genomic fingerprint that may help your physician map the best path to overcoming it.

We advocate for every patient to get their tumor genomically tested. Only through testing can we give patients their best chance at improved outcomes.

Learn More About Genomic Testing Patient-Doctor Discussion Guide
 
 
 
 

Blazing the trail to make genomic test results actionable

We develop drugs to inhibit the specific alterations that have been identified as drivers of cancer ⏤ no matter how rare.

Our lead drug candidate, seribantumab, inhibits tumor growth driven by NRG1 gene fusions. Seribantumab is being studied in CRESTONE, a Phase 2 trial for patients with solid tumors of any origin that test positive for an NRG1 fusion.

Learn More About CRESTONE

Laying the groundwork

SHAWN LELAND | JULY 2021

We have big ambitions for the potential of precision medicine at Elevation Oncology that are firmly grounded in our desire and commitment to build a sustainable drug development company along the way. Our milestone achievements this past quarter exemplify our ability to follow through on this commitment, and strengthen our foundation in 3 key areas.

Read the full letter 

JUNE 15, 2021

Caris Life Sciences and Elevation Oncology Announce Joint Discovery and Development Collaboration Focused on Oncogenic Fusions and Driver Mutations